Skip to main content

Zantac 75 News (Page 2)

FDA Medwatch Alert: Apotex Corp. Issues Voluntary Recall of Ranitidine Tablets 75mg and 150mg Due to Detection of an Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in the Product

September 25, 2019 – Apotex Corp. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) to the Retail level. Apotex has learned from the...

FDA Medwatch Alert: Sandoz Inc. Issues Voluntary Recall of Ranitidine Hydrochloride Capsules 150mg and 300mg Due to an Elevated Amount of Unexpected Impurity, N-Nitrosodimethylamine (NDMA) in the Product

September 23, 2019 – Sandoz Inc. is voluntarily recalling all quantities and lots within expiry of Ranitidine Hydrochloride Capsules in the US to the consumer level because of confirmed...

FDA Medwatch Alert: Safety Information: Ranitidine Generics - NDMA Found in Samples of Some Ranitidine Medicines

September 13, 2019 ISSUE: FDA has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

GERD, Eczema, Erosive Esophagitis, Duodenal Ulcer, Stomach Ulcer, Gastric Ulcer, Urticaria, Hives, Hiatal Hernia, Indigestion